- Home
- IPDN vs KTTA Comparison
IPDN vs KTTA Comparison
Compare IPDN & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- KTTA
- Stock Information
- Founded
- IPDN 2003
- KTTA 2020
- Country
- IPDN United States
- KTTA United States
- Employees
- IPDN N/A
- KTTA N/A
- Industry
- IPDN EDP Services
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- KTTA Health Care
- Exchange
- IPDN Nasdaq
- KTTA Nasdaq
- Market Cap
- IPDN 5.2M
- KTTA 5.5M
- IPO Year
- IPDN 2013
- KTTA 2021
- Fundamental
- Price
- IPDN $3.16
- KTTA $0.81
- Analyst Decision
- IPDN
- KTTA
- Analyst Count
- IPDN 0
- KTTA 0
- Target Price
- IPDN N/A
- KTTA N/A
- AVG Volume (30 Days)
- IPDN 2.7M
- KTTA 93.8K
- Earning Date
- IPDN 11-13-2025
- KTTA 11-12-2025
- Dividend Yield
- IPDN N/A
- KTTA N/A
- EPS Growth
- IPDN N/A
- KTTA N/A
- EPS
- IPDN N/A
- KTTA N/A
- Revenue
- IPDN $6,459,379.00
- KTTA N/A
- Revenue This Year
- IPDN N/A
- KTTA N/A
- Revenue Next Year
- IPDN N/A
- KTTA N/A
- P/E Ratio
- IPDN N/A
- KTTA N/A
- Revenue Growth
- IPDN N/A
- KTTA N/A
- 52 Week Low
- IPDN $0.97
- KTTA $0.65
- 52 Week High
- IPDN $12.39
- KTTA $5.45
- Technical
- Relative Strength Index (RSI)
- IPDN 45.73
- KTTA 61.44
- Support Level
- IPDN $3.54
- KTTA $0.70
- Resistance Level
- IPDN $4.07
- KTTA $0.84
- Average True Range (ATR)
- IPDN 0.45
- KTTA 0.03
- MACD
- IPDN -0.08
- KTTA 0.01
- Stochastic Oscillator
- IPDN 19.41
- KTTA 81.57
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).